Atrial fibrillation (AF) is an important risk factor for ischemic stroke (IS). Oral anticoagulation
(OAC) significantly reduces the risk of IS in AF but also increases the risk of systemic …

Purpose The aim of this clinical narrative review was to summarise the existing knowledge
on the use of anticoagulants and potential adverse events in older people at risk of falls with …

Background The safety and efficacy of oral anticoagulation for prevention of major adverse
cardiovascular events in people with atrial fibrillation and spontaneous intracranial …

Purpose To investigate the rate and timing of oral anticoagulant (OAC) resumption and its
safety in patients after intracerebral hemorrhage (ICH) in current clinical practice in Japan …

Abstract Purpose of Review Survivors of intracerebral hemorrhage (ICH) are not only at risk
for recurrent ICH but often also have vascular risk factors which predispose them to ischemic …

Background: The benefits and risks of starting anticoagulation therapy, such as direct oral
anticoagulations (DOACs) or warfarin, in atrial fibrillation (AF) patients with a history of …

Background The safety and efficacy of oral anticoagulation for prevention of major adverse
cardiovascular events in people with atrial fibrillation and spontaneous intracranial …

Atraumatic convexity subarachnoid haemorrhage describes spontaneous bleeding into the
convexities of the brain sulci without parenchymal involvement. Its many causes include …

In this study, we sought to investigate the effectiveness of inferior vena cava (IVC) filter
placement in reducing the incidence of venous thromboembolism (VTE) in patients …

Intracranial haemorrhage (ICH) is the most feared and lethal complication of oral
anticoagulant (OAC) therapy. Resumption of OAC following ICH has long posed a challenge …